The Enterprise Value as of September 2024 (TTM) for Annovis Bio, Inc. (ANVS) is 100.30M

According to Annovis Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 100.30M. This represents a change of -6.93% compared to the average of 107.77M of the last 4 quarters.

Annovis Bio, Inc. (ANVS) Historical Enterprise Value (quarterly & annually)

How has ANVS Enterprise Value performed in the past?

The mean historical Enterprise Value of Annovis Bio, Inc. over the last ten years is 74.60M. The current 100.30M Enterprise Value has changed 13.35% with respect to the historical average. Over the past ten years (40 quarters), ANVS's Enterprise Value was at its highest in in the June 2021 quarter at 581.21M. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.

Annovis Bio, Inc. (ANVS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Annovis Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Annovis Bio, Inc. (ANVS) Average Enterprise Value

How has ANVS Enterprise Value performed in the past?

The current Enterprise Value of Annovis Bio, Inc. (ANVS) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Annovis Bio, Inc. (ANVS) Enterprise Value vs. Peers

How is ANVS’s Enterprise Value compared to its peers?

Annovis Bio, Inc.’s Enterprise Value is less than Cassava Sciences, Inc. (1.13B), less than Axsome Therapeutics, Inc. (4.34B), greater than Reviva Pharmaceuticals Holdings, Inc. (33.56M), less than Seres Therapeutics, Inc. (299.11M), less than Anavex Life Sciences Corp. (336.10M), less than Iovance Biotherapeutics, Inc. (2.87B), less than Novavax, Inc. (1.67B), less than Anixa Biosciences, Inc. (107.13M), greater than TFF Pharmaceuticals, Inc. (3.55M), less than Immunome, Inc. (782.70M), greater than IN8bio, Inc. (10.13M), less than Acumen Pharmaceuticals, Inc. (113.46M), less than Inozyme Pharma, Inc. (408.51M), less than Terns Pharmaceuticals, Inc. (573.77M), less than Day One Biopharmaceuticals, Inc. (969.04M), greater than Galera Therapeutics, Inc. (-5796499.00), greater than Cue Biopharma, Inc. (8.98M), greater than Lantern Pharma Inc. (28.90M), less than Gracell Biotechnologies Inc. (5.46B),

Build a custom stock screener for Annovis Bio, Inc. (ANVS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Annovis Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Annovis Bio, Inc. (ANVS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Annovis Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.